Investigation of germline GFR alpha-1 mutations in Hirschsprung disease - PubMed (original) (raw)

Investigation of germline GFR alpha-1 mutations in Hirschsprung disease

S M Myers et al. J Med Genet. 1999 Mar.

Abstract

Inactivating mutations of the RET proto-oncogene and of one of its soluble ligand molecules, glial cell line derived neurotrophic factor (GDNF), have been found in a subset of patients with Hirschsprung disease (HSCR). However, the majority of HSCR mutations remain unidentified. As normal RET function requires a multicomponent ligand complex for activation, other members of the RET ligand complex are primary candidates for these mutations. We investigated the presence of mutations in another member of the RET signalling complex, GDNF family receptor alpha-1 (GFR alpha-1), in a panel of 269 independent cases of HSCR. We identified 10 polymorphisms at the GFR alpha-1 locus. Surprisingly, however, we did not identify any sequence variants in our HSCR population that were not also present in a normal control population. Our data suggest that mutations of the GFR alpha-1 gene are not a common aetiological event in HSCR.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1996 Jul 4;382(6586):76-9 - PubMed
    1. Hum Genet. 1998 Apr;102(4):474-8 - PubMed
    1. Science. 1993 May 21;260(5111):1130-2 - PubMed
    1. Development. 1993 Dec;119(4):1005-17 - PubMed
    1. Nature. 1994 Jan 27;367(6461):380-3 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources